FLX-787, Which Treats ALS-Associated Muscle Cramps, Wins FDA Fast Track Status
The U.S. Food and Drug Administration has granted fast track status to FLX-787, Flex Pharma‘s treatment for severe muscle…
Articles by Margarida Azevedo, MSc
10 Quotes to Help You When You’re Feeling Down
We know dealing with amyotrophic lateral sclerosis (ALS) sometimes feels like an uphill battle, both for the patients and the caregivers. You feel like…
Brainstorm Gets $16 Million California Grant for Trial of NurOwn, Its Stem Cell Therapy for ALS
Brainstorm Cell Therapeutics has received a $16 million grant from a state agency known as the California Institute for Regenerative…
Green Relief Reminds Florida Residents They Must No Longer Wait for Medical Marijuana
The Orlando-area medical marijuana company Green Relief is reminding Florida residents that the state no longer requires a 90-day waiting period…
Ipsen and Saol Partner to Promote Dysport in US for Spasticity, a Common Symptom in ALS
Ipsen Biopharmaceuticals has entered an exclusive three-year agreement with Saol Therapeutics to promote Dysport (abobotulinumtoxinA), a therapy…
700 Sites Enrolled in New Infusion Center Directory for ALS Patients Prescribed Radicava
Mitsubishi Tanabe Pharma America (MT Pharma America) has enrolled more than 700 sites of…
Level of Neurofilaments in Cerebrospinal Fluid Could Confirm ALS Diagnosis, Study Reports
Measuring neurofilaments in brain and spinal fluid appears to be a reliable way of confirming an ALS diagnosis, Belgian and German…
Israel’s BrainStorm Receives $2.1 Million Grant to Support Development of Stem-Cell Therapy NurOwn to Treat ALS
The Israel Innovation Authority (IIA) has awarded BrainStorm Cell Therapeutics a $2.1…
FDA Expands Approval of Dysport to Include Treatment of Lower-limb Adult Spasticity
The U.S. Food and Drug Administration has expanded its approval of Dysport (abobotulinumtoxinA) as a  treatment for spasticity in adults…
Flex Pharma, Which Is Developing a Therapy to Reduce Cramps and Shaking in ALS, Has New CEO
Flex Pharma, which develops therapies to reduce the cramps and shaking that are hallmarks of ALS and other neurological…